FG

Foram Gajendrabhai Mehta

Active Director Director DIN 03442872
DIN 03442872 First appointment Jul 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2011
Shareholding value •••• Premium profile

About Foram Gajendrabhai Mehta

Data last updated:

Foram Gajendrabhai Mehta is a Director at Avance Healthcare Private Limited (since 2011), Director at Oroance Management Consultancy Private Limited (since 2017) and Director at Avance Bliss Foundation (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Business Outsourcing and Non-Profit Organizations. The 3 current companies with reported revenue have a combined latest revenue of ₹32.11 Cr; the largest is Avance Healthcare Private Limited at ₹21.12 Cr (FY 2025). Earlier, Foram Gajendrabhai Mehta was a Director at Biovy Healthcare Private Limited (2011–2013).

DIN 03442872
Primary Designation Director
Industry Pharma
First Appointment 11 Jul 2011
Oldest Company Age 15 yrs
Largest company Avance Healthcare Private Limited · ₹21.12 Cr (FY 2025)
Combined revenue ₹32.11 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avance Healthcare Private Limited U24230GJ2011PTC066289
Director11 Jul 20112011₹21.12 Cr (FY 2025)Active
Director22 Jun 20172016₹10.84 Cr (FY 2025)Active
Avance Bliss Foundation U85300GJ2023NPL137969
Director02 Jan 20232023₹15 Lakh (FY 2025)Active
Avance Research Private Limited U71200GJ2024PTC151450
Director13 May 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biovy Healthcare Private Limited U74120MH2011PTC220170
Director26 Jul 20112011₹2,680 (FY 2020)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Avance Healthcare Private Limited
Oroance Management Consultancy Private Limited
Avance Bliss Foundation
Avance Research Private Limited
Premium access

Shareholding and investment profile for Foram Gajendrabhai Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Foram Gajendrabhai Mehta

Foram Gajendrabhai Mehta currently holds 4 directorships: Avance Healthcare Private Limited (Director, since 11 Jul 2011, revenue ₹21.12 Cr (FY 2025)); Oroance Management Consultancy Private Limited (Director, since 22 Jun 2017, revenue ₹10.84 Cr (FY 2025)); Avance Bliss Foundation (Director, since 02 Jan 2023, revenue ₹15 Lakh (FY 2025)); Avance Research Private Limited (Director, since 13 May 2024).

Foram Gajendrabhai Mehta was first appointed on 11 Jul 2011 as Director at Avance Healthcare Private Limited. The most recent appointment on record is 13 May 2024 at Avance Research Private Limited.

The 3 current companies of Foram Gajendrabhai Mehta that report revenue have a combined latest revenue of ₹32.11 Cr: Avance Healthcare Private Limited ₹21.12 Cr (FY 2025); Oroance Management Consultancy Private Limited ₹10.84 Cr (FY 2025); Avance Bliss Foundation ₹15 Lakh (FY 2025).

Foram Gajendrabhai Mehta held 1 earlier board appointment: Biovy Healthcare Private Limited (Director, 26 Jul 2011 to 15 Feb 2013).

The current boards of Foram Gajendrabhai Mehta's companies include Gajendra Umedchand Mehta (Avance Healthcare Private Limited), Saurabh Gajendra Mehta (Avance Healthcare Private Limited), Abhijit Rajendra Gole (Avance Research Private Limited), Gauri Tushar Korday (Avance Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available